美国癌症幸存者后续原发性癌症发病率:1975-2019年年龄-时期-队列分析
SPC发病率随首诊年龄增长而上升,女性35-39岁为915/10万人年,75-79岁升至1980/10万人年;男性从1228/10万人年升至2945/10万人年。出生队列风险在1935-1945年达峰后下降,但女性肺癌和男性膀胱癌幸存者例外。
要点
- SPC发病率随首诊年龄增长而上升,男性上升幅度大于女性。
- 出生队列SPC风险在1935-1945年达峰后下降,但女性肺癌和男性膀胱癌幸存者持续上升。
- 女性肺癌幸存者SPC发病率1975-1979至2015-2019年间上升60%(IRR=1.60,95%CI 1.22-2.09,p<0.001)。
核心结论
- SPC风险呈现复杂的部位和性别特异性时间模式,需结合年龄、出生队列和首诊癌症部位制定幸存者照护策略。
主要发现
- 女性SPC发病率从35-39岁的915/10万人年升至75-79岁的1980/10万人年,男性从1228/10万人年升至2945/10万人年。
- 出生队列SPC风险在1935-1945年达峰后下降,但女性肺癌和男性膀胱癌幸存者风险持续上升。
- 女性肺癌幸存者SPC发病率1975-1979至2015-2019年间上升60%(IRR=1.60,95%CI 1.22-2.09,p<0.001)。
临床怎么用
- 幸存者照护应结合首诊年龄、出生队列和首诊癌症部位进行风险分层。
局限性
- 年龄-时期-队列分析为描述性性质。
- SEER数据缺乏治疗、遗传和生活方式信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The growing population of cancer survivors faces elevated risks of subsequent primary cancers (SPCs), yet temporal patterns in SPC incidence remain poorly understood. This study aims to characterize age-, period-, and cohort-specific patterns in SPC incidence among US cancer survivors using population-based data. METHODS AND FINDINGS: We conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) 8 registries, identifying 3.36 million individuals diagnosed with a first primary cancer between 1975 and 2019. Survivors were followed through 2022 to estimate the incidence of SPCs. We used age-period-cohort analysis to estimate longitudinal age curves, cohort and period rate ratios, and annual percent changes in SPC incidence. Analyses were stratified by sex and the five most common index cancer sites. During 29.5 million person‑years of follow‑up, 510,340 SPCs were observed. SPC incidence increased with age at index cancer diagnosis, rising among females from 915 per 100,000 person‑years at ages 35-39 years to 1,980 per 100,000 at ages 75-79 years, and among males from 1,228 per 100,000 to 2,945 per 100,000 across the same age groups, demonstrating steeper rises in men. Cohort-specific SPC risk peaked in the 1935-1945 birth cohorts and declined in later cohorts, except among female survivors of lung cancer and male survivors of bladder cancer, where risks continued to rise. Period patterns showed overall declines in SPC incidence, particularly among survivors diagnosed at a younger age, but increasing risks among survivors diagnosed at an older age and survivors of specific index cancer sites. Notably, SPC incidence rose by 60% among female lung cancer survivors between 1975-1979 and 2015-2019 (incidence rate ratio = 1.60, 95% CI [1.22, 2.09]; p < 0.001). Main limitations include the descriptive nature of age-period-cohort analyses and the absence of treatment, genetic, and lifestyle data in SEER. CONCLUSIONS: SPC risk is shaped by complex, site- and sex-specific temporal patterns. These findings underscore the need for tailored survivorship care strategies that incorporate age, cohort, and index cancer site to mitigate future SPC burden.
引用
- Cheng HG, Aduse-Poku L, McGill C, et al. Subsequent primary cancer incidence among cancer survivors in the United States, 1975-2019: An age-period-cohort analysis. PLoS Med. 2026. PMID: 42048284. doi:10.1371/journal.pmed.1005034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。